The outsourcing firm Serco has upgraded its revenue forecast due to persevering with strong revenues from its lucrative contract to run components of the UK authorities’s Covid-19 test-and-trace service.
The corporate on Monday stated its underlying buying and selling revenue for 2021 can be £15m larger than beforehand thought, at about £200m. Shares rose 5% in early buying and selling, making Serco the highest riser on the FTSE 250.
Serco runs massive components of the largely privatised service, which is labelled as NHS check and hint. It runs 1 / 4 of the testing websites and half the “tier 3” contact tracers, who’re primarily tasked with phoning the contacts of people that have examined optimistic.
Learn extra of Jasper Jolly’s report right here: Serco upgrades profit forecast as Covid test-and-trace work soars